Claims Facing Eliquis

Drug manufacturing companies are responsible for advising the public of all potential side effects associated with using their products.


The creators of the blood thinning medication Eliquis are being sued for neglecting to warn users of potential life-threatening risks including:

  • Blood...
Read More
Get Justice Now



The Food and Drug Administration (FDA) approves Eliquis in order to treat blood clots occurring in non-valvular atrial fibrillation, and to reduce stroke
Eliquis is approved in March as a way to reduce the chances of blood clots in patients who receive hip or knee replacement surgery
In August, the FDA approved the drug for the treatment of thrombosis and pulmonary embolism
Lawsuits are being filed against the drug’s manufacturers as a result from numerous patients experiencing uncontrolled bleeding while using the drug

Have you
or a loved one

been seriously injured by
a Eliquis prescription drug?

Get Justice Now

How Does Eliquis Work?

In order to prevent platelets in blood from sticking together and forming a blood clot, doctors can
prescribe Eliquis (apixaban). Used as a method of lowering risk of stroke, patients use this drug
as a method of lowering the risk of stroke as a result of atrial fibrillation. Eliquis can also be used
after knee of hip replacement surgery in order to prevent deep vein...

Read More

Lawsuit Information Regarding Eliquis

Manufacturers Pfizer and Bristol-Meyer are currently facing lawsuits, stating that antidote to stop uncontrolled or internal bleeding caused by Eliquis was not provided to doctors. These claims also include a failure of the manufacturing companies to properly warn patients of the life-threatening risks the drugs may cause, including internal or uncontrolled bleeding, deep...

Read More

Cases Filed Against Eliquis

Donald Herschell was prescribed Eliquis in 2014 as a way to treat his irregular heartbeat. After two months, he suffered an irreversible gastrointestinal hemorrhage, which resulted in him dying in...

Read More